Abstract
Introduction: In 2016, NICE CG 95 was revised to recommend CT coronary angiography (CTCA) as the first line test for angina or non-anginal chest pain with ECG abnormalities. Additional capacity modelling, to deliver this guideline, performed by the British Society of Cardiac Imaging, demonstrated a mismatch with current capacity. There is an additional disparity between a district general hospital (DGH) and tertiary centres to deliver CTCA in England. The initial point of contact for patients will be their local DHG. 5 years on, we sought to assess the local impact CTCA has had; to establish if it truly has offered an acceptable alternative to invasive coronary angiography (ICA) in our population of approximately 800,000, and to predict its fiscal impact.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have